RecruitingPhase 3NCT06126224
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Malvern, PA · +69 more sites
1 recruiting alzheimer's disease studies with a site in Malvern, PA.
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Malvern, PA · +69 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.